Alexion Pharmaceuticals

$163.68
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

+$6.14 (+3.90%) Today
$0.00 (0.00%) As of 12:00 AM UTC after-hours

Why Robinhood?

You can buy or sell ALXN and other stocks, options, and ETFs commission-free!

About ALXN

Alexion Pharmaceuticals, Inc. operates as a biopharmaceutical company. The firm focuses on serving patients with devastating and ultra-rare disorders through the development and commercialization of life-transforming therapeutic products.

CEO
Ludwig N. Hantson
Employees
3,837
Headquarters
Boston, Massachusetts
Founded
1992
Market Cap
35.29B
Price-Earnings Ratio
60.22
Dividend Yield
—
Average Volume
2.18M
High Today
$164.57
Low Today
$163.54
Open Price
$163.96
Volume
7.31M
52 Week High
$164.60
52 Week Low
$94.82

ALXN Earnings

$0.00
$1.08
$2.16
$3.24
Q3 FY19
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Q1 FY21
Estimated
— per share
Actual
Expected May 5, Pre-Market

You May Also Like

IHY
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure